|
RAPT Therapeutics, Inc.
Ticker Symbol: RAPT* CUSIP: 75382E109 Exchange: NGM
* NOTE: This security is no longer trading as of 3/03/2026
Company's Online Profile
BUSINESS: RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing proprietary drug discovery and development engine, they are developing highly selective small molecules designed to modulate the critical immune responses underlying these diseases.
|
IPO - 10/31/2019 - 3.00 Million Shares @ $12.00 /share.
Link to IPO Prospectus
Mid Cap Stock -
Market Value $ Million
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: 561 Eccles Avenue, South San Francisco, CA 9408 |
| Main Phone Number |
650-489-9000 |
| Fax Number |
Not Available |
| CEO - Brian Wong |
CFO - Rodney Young |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
